Blood biomarkers: Towards a faster and more accessible diagnosis of Alzheimer’s disease
The introduction of blood biomarkers for Alzheimer’s disease is revolutionizing the biological diagnosis of this disease, enabling faster diagnosis i1
The introduction of blood biomarkers for Alzheimer’s disease is revolutionizing the biological diagnosis of this disease, enabling faster diagnosis i1
Written By:
The treatments available for Alzheimer’s disease are most effective in the early stages, when it is still asymptomatic. That is why an early diagnosi1
The Translational research programme for brain disorders was created to add to our knowledge of the biological foundations and factors that predispos1
HUB Alzheimer Barcelona is a pioneering collaborative initiative rooted in a commitment to transform the future of research and provide support for p1
They are Metabolism and disease programme (MetaDis) and Translational research programme for brain disorders
IDIBAPS looks for talented professionals to meet the needs that appear periodically.
Enter